Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma

Published 2019 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma
Authors
Keywords
Metastatic renal cell carcinomas, Immunotherapy, Nivolumab, Ipilimumab, Second-line tyrosine kinase inhibitors, Outcomes
Journal
EUROPEAN JOURNAL OF CANCER
Volume 108, Issue -, Pages 33-40
Publisher
Elsevier BV
Online
2019-01-05
DOI
10.1016/j.ejca.2018.11.031

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.